Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy

Epilepsia
Hero BartmannH Potschka

Abstract

Based on experimental findings, overexpression of P-glycoprotein at the blood-brain barrier has been suggested to be a contributor to pharmacoresistance of the epileptic brain. We test a technique for evaluation of interindividual differences of elevated transporter function, through microPET analysis of the impact of the P-glycoprotein modulator tariquidar. The preclinical study is intended for eventual translation to clinical research of patients with pharmacoresistant seizure disorders. We made a microPET evaluation of the effects of tariquidar on the brain kinetics of the P-glycoprotein substrate [(18) F]MPPF in a rat model with spontaneous recurrent seizures, in which it has previously been demonstrated that phenobarbital nonresponders exhibit higher P-glycoprotein expression than do phenobarbital responders. Mean baseline parametric maps of the [(18) F]MPPF unidirectional blood-brain clearance (K(1) ; ml/g per min) and the efflux rate constant (k(2) ; per min) did not differ between the nonresponder and responder group. Tariquidar pretreatment increased the magnitude of [(18) F]MPPF K(1) in hippocampus by a mean of 142% in the nonresponders, which significantly exceeded the 92% increase observed in the responder group. Th...Continue Reading

References

Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Jan 1, 1995·Brain Research Bulletin·A W TogaK Ambach
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·S DeyS V Ambudkar
May 30, 1998·Journal of Neuroscience Methods·T SaitoT Nemoto
Nov 9, 2000·European Journal of Pharmacology·J PasschierW Vaalburg
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Hilary Thomas, Helen M Coley
Aug 26, 2004·The Annals of Pharmacotherapy·Monica A SummersJames W McAuley
May 25, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Philip H ElsingaWillem Vaalburg
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Jul 19, 2005·Nature Reviews. Neuroscience·Wolfgang Löscher, Heidrun Potschka
Feb 14, 2006·Current Drug Metabolism·E SrinivasG Narahari Sastry
Apr 13, 2007·Expert Review of Anticancer Therapy·Elizabeth Fox, Susan E Bates
Jul 17, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nicolas CostesDidier Le Bars
Apr 4, 2008·Journal of Pharmaceutical Sciences·Stina SyvänenMargareta Hammarlund-Udenaes
Jul 8, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Goran LaćanWilliam P Melega
Jul 18, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Jens P BankstahlOliver Langer
Sep 11, 2008·Current Clinical Pharmacology·Alberto MagnascoGian Marco Ghiggeri
Oct 1, 2008·Neuropharmacology·Carlos Luna-TortósWolfgang Löscher
Mar 24, 2009·Epilepsy Research·Paola IannettiFederico Zara
Jun 6, 2009·The Journal of Pharmacology and Experimental Therapeutics·Anton PekcecHeidrun Potschka
Jul 21, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mark MuziJashvant D Unadkat
Jul 2, 2010·British Journal of Pharmacology·J SchlichtigerH Potschka

❮ Previous
Next ❯

Citations

Feb 21, 2013·ACS Chemical Neuroscience·Stina Syvänen, Jonas Eriksson
Feb 22, 2012·Neuroscience and Biobehavioral Reviews·Kanwar VirdeeJeffrey W Dalley
Dec 27, 2011·Advanced Drug Delivery Reviews·Chunbo ZhangLarry Baum
Dec 6, 2011·Advanced Drug Delivery Reviews·Eleonora AronicaJan A Gorter
Dec 3, 2014·Seminars in Cell & Developmental Biology·Yoash ChassidimIlan Shelef
Nov 25, 2016·Epilepsia·Erwin A van VlietPaolo Federico
Feb 15, 2017·Molecular Pharmaceutics·Anika M S HartzBjoern Bauer
Aug 22, 2014·Journal of Medicinal Chemistry·Markus PielFrank Rösch
Jul 25, 2019·Annals of Neurology·Cenglin XuZhong Chen
Oct 26, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Viktoria ZoufalOliver Langer
Jun 30, 2018·Neuroinformatics·Francisco J López-GonzálezNúria Roé-Vellvé
Jan 11, 2019·International Journal of Molecular Sciences·Sandesh D ReddyDoodipala Samba Reddy
Sep 10, 2021·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Louise BreuilNicolas Tournier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.